Zydus Lifesciences Limited received final approval from the US Food and Drug Administration (USFDA) to manufacture Ketoconazole Shampoo, 2 per cent, according to the announcement issued by the ...

The stock of Zydus Lifesciences has been in a steady decline since August last year after facing resistance at ₹1,300. After witnessing some consolidation between ₹940 and ₹1,000 in December ...

Zydus Lifesciences Limited (Formerly known as ... There is currently no vaccine to prevent or medicine to treat chikungunya virus infection.On 30 September 2016, Cadila Healthcare and Medicines ...

Duke clinicians and patients discuss how approaches such as talk, music, and art therapy can address psychosocial issues that cancer survivors often face. Beyond Cancer: Building Bridges Experts ...

Medical research involves research in a wide range of fields, such as biology, chemistry, pharmacology and toxicology with the goal of developing new medicines or medical procedures or improving ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Zydus Lifesciences Ltd. is a Public Limited Listed company incorporated on 15/05/1995 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is ...

Nippon India Small Cap Fund - Direct (IDCW) 467.76 29,95,942 0.92 Nippon India Small Cap Fund - Direct (G) 467.76 29,95,942 0.92 Nippon India Small Cap Fund - Direct ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Zydus Lifesciences launches ANVIMO, a breakthrough drug for preventing Cytomegalovirus infection in transplant patients, offering a safer and more affordable treatment option. Mar 05, 2025 15:16 Zydus ...

*Ministry of Corporate Affairs, 2019, Company/LLP Data, (Government of India administrative body to govern and regulate corporate affairs through the Companies Act ...